Trump Orders ‘a Lot’ of Ketamine for Depressed Veterans

  • Post author:
  • Reading time:2 mins read
Esketamine, a nasal spray derivative of the horse tranquilizer, Ketamine.

President Donald Trump said on Wednesday that the government will purchase “a lot” of the drug esketamine, a derivative of ketamine.

Though ketamine is known as a recreational hallucinogen, Trump asserted that a new nasal-spray derivative would be of great benefit to veterans with depression. As he left the White House for a veterans’ conference in Kentucky, he told reporters that he had instructed the Department of Veterans Affairs to make a large purchase—overriding a recent decision by the doctors who manage the hospitals’ formulary of which drugs are to be prescribed.

“There’s a product that’s made right now that just came out by Johnson & Johnson which has a tremendously positive—pretty short-term, but nevertheless positive—effect,” Trump said. But that statement is contrary to the evidence.

A review by the Food and Drug Administration of what limited studies have been done with esketamine found mixed results, leaving many scientists unsure if the drug is indeed effective and safe. Just last week, the agency published a report that said the drug was not reliably better than placebo.

With suicide and depression levels continuing to be a focus of research, treatments are needed. Is Esketamine a viable option? The article continues Here, in the Atlantic :